Rallybio Corp business relationships

Companies named in Rallybio Corp’s 10-K filed 2026-03-16, and public companies whose annual reports name Rallybio Corp. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.0 / 10
AI naming: 27 / 100
Agent readiness: 25 / 100
AI adoption: 0 / 100

Named in Rallybio Corp’s annual report 4

JOHNSON & JOHNSON (JNJ)Partner7.7
“Collaboration Agreement with Johnson & Johnson” SEC filing
Sanofi (SNY)Licensor6.7
“Under the Sanofi License Agreement, Sanofi provides Rallybio IPE with worldwide exclusive rights to Sanofi's KY1066, which is now referred to as RLYB331.” SEC filing
AbCellera Biologics Inc. (ABCL)Partner6.1
“In December 2022, the Company entered into a multi-year, multi-target collaboration with AbCellera Biologics ("AbCellera") to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases.” SEC filing
Affibody ABLicensor4.2
“Product License Agreement with Affibody AB” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.